(Q28741022)
Statements
Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings (English)
0 references
2011
0 references
6
0 references
8
0 references
e23720
0 references
22 August 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference